Login / Signup
Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Sai Chen
Hefei Ren
Xiaomin Zhang
Liu Chang
Zhenhua Wang
Hongkun Wu
Jiafeng Zhang
Jigang Ren
Lin Zhou
Published in:
Journal of clinical laboratory analysis (2022)
Dysregulated m6A and its related factors in pancreatic cancer cells and patients indicate their potential values as novel biomarkers in pancreatic cancer diagnosis and targeted therapy.
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
stem cells
patient reported outcomes
risk assessment
bone marrow